GGrantIndex
← Search

CLINICAL TRIAL: A PHASE II, RANDOMIZED, FOUR-WAY CROSSOVER STUDY TO COMPARE THE

$24,852M01FY2008RRNIH

Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center, Torrance CA

Investigators

Linked publications & trials

View original record on NIH RePORTER →